Women’s health isn’t fragmented. Why are our solutions?
Women’s health has traditionally been addressed in silos—prenatal nutrition, skin health, or healthy ageing—yet the underlying biology is continuous. Across life stages, common mechanisms such as oxidative stress, cellular signalling, and structural integrity shape outcomes ranging from foetal development to collagen decline and emotional resilience.
If the biology is continuous, should interventions still be episodic?
Carotenoids are increasingly recognised as nutrients that act across this continuum. Beyond their antioxidant role, compounds such as lutein and zeaxanthin are selectively accumulated in neural tissues, supporting functional development early in life and cellular protection later.
This dual relevance raises an important consideration:
Are we fully leveraging nutrients that naturally span multiple physiological endpoints?
During pregnancy, this becomes particularly relevant. Maternal nutrition directly influences fetal development, with lutein and zeaxanthin actively transferred and deposited in developing neural tissues—supporting early visual and cognitive development.
At this stage, the eye–brain axis is not a theoretical construct—it is being formed.
If early neural deposition defines later function, how early should targeted nutrition begin?
However, effective prenatal nutrition is not only about nutrient presence, but delivery and utilisation. Phospholipids play a critical role here, serving as essential components of neuronal membranes and supporting cellular signalling and brain development. When combined with carotenoids, they enhance absorption and bioavailability, supporting efficient nutrient delivery and utilisation.
This integrated approach is reflected in formulations such as Lute-gen® Mom, designed to support maternal wellbeing alongside foundational aspects of foetal neurodevelopment.
As women transition into perimenopause (40–55 years), the same biological pathways manifest differently. Declining oestrogen levels accelerate collagen degradation, impair skin barrier function, and increase oxidative stress—leading to reduced elasticity, dryness, and visible signs of ageing.
These changes are not merely cosmetic but reflect deeper structural and cellular shifts.
Clinical evidence with CaroRite™ highlights how a multi-carotenoid approach can address these changes. In a 12-week randomised, double-blind, placebo-controlled study in women aged 40–55 years, supplementation led to a significant improvement in skin barrier function (31% reduction in TEWL) and a meaningful increase in skin collagen thickness (~12% from baseline), indicating enhanced dermal structure and integrity.
These outcomes demonstrate that carotenoids influence not only surface-level appearance, but supports key biological pathways associated with skin ageing.
At the same time, this life stage is often associated with increased psychological and physiological stress. A separate clinical study with CaroRite™ demonstrated significant improvements associated with measures of psychological wellbeing in individuals over 35 years, alongside modulation of oxidative stress markers.
Together, these findings position carotenoids not as single-benefit ingredients, but as a foundational platform for women’s health. From supporting foetal neural development to preserving collagen structure and emotional wellbeing in mid-life, carotenoid-based interventions address shared biological pathways across life stages.
If one class of nutrients can influence multiple life stages, should strategy move from product-based to pathway-based thinking?
This lifecycle perspective moves beyond adequacy—toward a more integrated, science-driven model of women’s health that reflects how the body evolves over time.
“These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”
